In PDAC, disruption of circadian clock can be evidenced by bioinformatics and gene expression studies [23], revealing altered activities of core clock genes, as compared to normal pancreatic tissue-derived ones, while it is associated with faster tumor growth, reduced survival rate, and increased chemotherapy resistance [24]. This evidence concerns the gene CLOCK and neoplasm.